FDA halts use of Regeneron, other monoclonal antibody COVID treatment, DeSantis says move ‘reckless’

The agency’s announcement Monday was followed by the Department of Health and Human Services stopping, at least for now, the distribution of the antibody medications made by Regeneron Pharmaceuticals and Eli Lilly, according to The Washington Post.
Regeneron became well known in November 2020 after President Trump received it to treat his COVID infection while the drug was still in early clinical trials and praised its effectiveness. [ Source: Just the News (Read More…) ]
Worthy News reports from a biblical worldview with a commitment to accuracy, transparency, and editorial independence. Learn more about About Worthy News, our Editorial Standards, AI Use Policy, Ownership of Worthy News, News Tips and Corrections, and Worthy News Staff.
💡 Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌
